Targeted brain stimulation for OCD with contamination symptoms
Part of Mental health clinical trials.
This study tests a personalized brain-stimulation approach to help people with obsessive-compulsive disorder (OCD) focused on contamination worries. If you have the “contamination” type of OCD and meet the safety and medication rules, you may be able to join and see whether this targeted treatment reduces symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re age 18 to 55
- Your main diagnosis is OCD
- Your OCD symptoms mostly involve contamination worries (based on a specific OCD severity rating)
- Your contamination symptom score is at least 8 on the study scale
- You either take no psychiatric meds or you’ve been on a stable dose for at least 4 weeks (no changes allowed during the study)
- You haven’t started a new exposure/response prevention therapy (ERP) in the last 4 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a gentle brain stimulation (tDCS) combined with facing your fears can help people with hard-to-treat OCD. If you've tried multiple treatments without relief, this study may offer a new option.
This trial tests a non-invasive brain stimulation technique called tDCS (which uses a mild electrical current on the scalp) to see if it can reduce OCD symptoms. It is for people whose OCD has not improved with standard treatments.
This study tests whether a quick form of magnetic brain stimulation (rTMS) can help hospitalized patients with obsessive-compulsive disorder (OCD) who are also doing exposure and response prevention therapy.
This study tests a new type of brain stimulation called transcranial temporal interference stimulation (tTIS) to see if it helps reduce OCD symptoms. It uses gentle electrical currents to target brain areas linked to OCD, and the researchers will also scan your brain to understand how it works.
This trial explores how stem cells and innovative treatments might help people with obsessive-compulsive disorder (OCD). It includes people who respond well to medication and those who do not. The goal is to better understand OCD and find new ways to treat it.
This study tests whether combining transcranial magnetic stimulation (TMS) with exposure therapy can help reduce OCD symptoms in young people aged 12-21. TMS is a non-invasive brain stimulation technique. The study aims to see if this combination is more effective than exposure therapy alone.
Hear when a new Obsessive-Compulsive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.